Selected article for: "cell type and infection efficiency"

Author: Wilkins, Jordan; Zheng, Yi-Min; Yu, Jingyou; Liang, Chen; Liu, Shan-Lu
Title: Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV
  • Document date: 2016_6_3
  • ID: 1m1woscb_45
    Snippet: The IFITM proteins are capable of restricting viruses at various stages of infection [12, 13, 19, 29, 69] . We sought to determine if there was a particular stage during the HIV-1 life cycle in which nonhuman primate IFITMs inhibit HIV-1 compared to that of human IFITMs. Previously, our lab determined that human IFITMs restrict HIV-1 in part by antagonizing HIV-1 envelope [29] . In this work we found that interaction of envelope with OWM (L'Hoest.....
    Document: The IFITM proteins are capable of restricting viruses at various stages of infection [12, 13, 19, 29, 69] . We sought to determine if there was a particular stage during the HIV-1 life cycle in which nonhuman primate IFITMs inhibit HIV-1 compared to that of human IFITMs. Previously, our lab determined that human IFITMs restrict HIV-1 in part by antagonizing HIV-1 envelope [29] . In this work we found that interaction of envelope with OWM (L'Hoest's) IFITM3 was conserved (Fig 3) . However, only a slight increase (about 20%) in binding efficiency between OWM IFITM3 and HIV-1 envelope was observed (Fig 3) . However, cell-to-cell transmission data clearly demonstrated that OWM IFITM3 is more efficient than human IFITM3 to reduce HIV-1 cell-to-cell spread and prolonged viral replication (Fig 5) . These results together suggest that the main step of IFITM mediated restriction of HIV-1 occurs in the viral producer cells and is during cell-to-cell spread. It should be noted that the efficiency of HIV-1 cell-to-cell infection and replication in the presence of IFITMs are sometimes cell-type dependent [29] .

    Search related documents:
    Co phrase search for related documents
    • cell cell and IFITM protein: 1, 2, 3
    • cell cell and infection stage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • cell cell and life cycle: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell cell and nonhuman primate IFITMs inhibit: 1
    • cell cell and particular stage: 1
    • cell cell and producer cell: 1, 2, 3
    • cell cell infection and envelope interaction: 1
    • cell cell infection and IFITM protein: 1
    • cell cell infection and infection stage: 1
    • cell cell infection and life cycle: 1, 2, 3, 4
    • cell cell infection and nonhuman primate IFITMs inhibit: 1
    • cell cell spread and life cycle: 1, 2, 3, 4, 5, 6, 7
    • cell cell spread and nonhuman primate IFITMs inhibit: 1
    • cell type and IFITM protein: 1
    • cell type and infection stage: 1, 2, 3, 4, 5, 6
    • cell type and life cycle: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • cell type and producer cell: 1, 2, 3
    • envelope interaction and IFITM protein: 1
    • envelope interaction and OWM envelope interaction: 1